NO890681L - Fremgangsmaate for fremstilling av alkanoyl- og aroyloxazoloner. - Google Patents
Fremgangsmaate for fremstilling av alkanoyl- og aroyloxazoloner.Info
- Publication number
- NO890681L NO890681L NO89890681A NO890681A NO890681L NO 890681 L NO890681 L NO 890681L NO 89890681 A NO89890681 A NO 89890681A NO 890681 A NO890681 A NO 890681A NO 890681 L NO890681 L NO 890681L
- Authority
- NO
- Norway
- Prior art keywords
- alkyl
- preparation
- aroyloxazolons
- alkanoyl
- procedure
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/36—One oxygen atom
- C07D263/38—One oxygen atom attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Cardiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Heart & Thoracic Surgery (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/157,430 US4866182A (en) | 1988-02-18 | 1988-02-18 | Cardiotonic alkanoyl and aroyl oxazolones |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO890681D0 NO890681D0 (no) | 1989-02-17 |
| NO890681L true NO890681L (no) | 1989-08-21 |
Family
ID=22563682
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO89890681A NO890681L (no) | 1988-02-18 | 1989-02-17 | Fremgangsmaate for fremstilling av alkanoyl- og aroyloxazoloner. |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US4866182A (ja) |
| EP (1) | EP0329070B1 (ja) |
| JP (1) | JP2811577B2 (ja) |
| KR (1) | KR960014794B1 (ja) |
| CN (1) | CN1022035C (ja) |
| AT (1) | ATE99681T1 (ja) |
| AU (1) | AU614029B2 (ja) |
| CA (1) | CA1334201C (ja) |
| DE (1) | DE68911944T2 (ja) |
| DK (1) | DK74889A (ja) |
| ES (1) | ES2061748T3 (ja) |
| FI (1) | FI890694A (ja) |
| HU (1) | HU206880B (ja) |
| IL (1) | IL89302A (ja) |
| NO (1) | NO890681L (ja) |
| NZ (1) | NZ227977A (ja) |
| PH (1) | PH26260A (ja) |
| PT (1) | PT89749B (ja) |
| ZA (1) | ZA891111B (ja) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5437491A (en) * | 1994-04-07 | 1995-08-01 | Illinois Tool Works Inc. | Fuel door housing |
| DE4429461A1 (de) * | 1994-08-19 | 1996-02-22 | Merck Patent Gmbh | Adhäsionsrezeptor-Antagonisten |
| ES2125161B1 (es) | 1996-03-21 | 1999-11-16 | Grupo Farmaceutico Almirall S | Nuevos derivados de 2-(3h)-oxazolona. |
| CN102993075A (zh) * | 2012-11-29 | 2013-03-27 | 江苏长青农化股份有限公司 | 硫脲类杀虫杀螨剂丁醚脲的合成工艺 |
| SI3303330T1 (sl) | 2015-06-03 | 2019-08-30 | Bristol-Myers Squibb Company | Agonisti 4-hidroksi-3-(heteroaril)piridin-2-on apj za uporabo pri zdravljenju kardiovaskularnih motenj |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3514465A (en) * | 1966-12-30 | 1970-05-26 | Degussa | Certain thiazolyl- and pyridinylaminoketones |
| US4303439A (en) * | 1979-10-01 | 1981-12-01 | Monsanto Company | 2-Substituted-4-alkyl or trihaloalkyl-5-oxazolecarboxylic acids as safening agents |
| JPS59100977A (ja) * | 1982-12-01 | 1984-06-11 | Omron Tateisi Electronics Co | 記録情報出力方法 |
| DE3370170D1 (en) * | 1982-12-18 | 1987-04-16 | Rinninger Hans & Sohn | Paving block |
| DE3246957A1 (de) * | 1982-12-18 | 1984-06-20 | Varta Batterie Ag, 3000 Hannover | Galvanisches element |
| US4762849A (en) * | 1985-10-15 | 1988-08-09 | Merrell Dow Pharmaceuticals Inc. | Cardiotonic alkanoylthiazolones |
| US4623651A (en) * | 1985-10-15 | 1986-11-18 | Merrell Dow Pharmaceuticals Inc. | Cardiotonic heterocyclocarbonyl- and acetyl-thiazolones |
| CA1266268A (en) * | 1985-10-15 | 1990-02-27 | J. Martin Grisar | Cardiotonic aroylthiazolones |
| US4728661A (en) * | 1985-11-13 | 1988-03-01 | Merrell Dow Pharmaceuticals Inc. | Cardiotonic phenyl oxazolones |
| US4670450A (en) * | 1985-11-13 | 1987-06-02 | Merrell Dow Pharmaceuticals Inc. | Cardiotonic thiazolones |
| US4689353A (en) * | 1986-02-21 | 1987-08-25 | The Dow Chemical Company | Hydroxy and amino-functional polyahls containing carbonate, urethane and/or urea moieties |
-
1988
- 1988-02-18 US US07/157,430 patent/US4866182A/en not_active Expired - Lifetime
-
1989
- 1989-02-13 AU AU29906/89A patent/AU614029B2/en not_active Ceased
- 1989-02-13 ZA ZA891111A patent/ZA891111B/xx unknown
- 1989-02-14 FI FI890694A patent/FI890694A/fi not_active Application Discontinuation
- 1989-02-14 DE DE68911944T patent/DE68911944T2/de not_active Expired - Fee Related
- 1989-02-14 NZ NZ227977A patent/NZ227977A/xx unknown
- 1989-02-14 AT AT89102496T patent/ATE99681T1/de not_active IP Right Cessation
- 1989-02-14 EP EP89102496A patent/EP0329070B1/en not_active Expired - Lifetime
- 1989-02-14 ES ES89102496T patent/ES2061748T3/es not_active Expired - Lifetime
- 1989-02-15 IL IL89302A patent/IL89302A/xx not_active IP Right Cessation
- 1989-02-15 PH PH38196A patent/PH26260A/en unknown
- 1989-02-15 CA CA000591184A patent/CA1334201C/en not_active Expired - Fee Related
- 1989-02-16 HU HU89778A patent/HU206880B/hu not_active IP Right Cessation
- 1989-02-16 JP JP1035200A patent/JP2811577B2/ja not_active Expired - Fee Related
- 1989-02-17 PT PT89749A patent/PT89749B/pt not_active IP Right Cessation
- 1989-02-17 DK DK074889A patent/DK74889A/da not_active Application Discontinuation
- 1989-02-17 NO NO89890681A patent/NO890681L/no unknown
- 1989-02-17 KR KR89001825A patent/KR960014794B1/ko not_active IP Right Cessation
- 1989-02-18 CN CN89102012A patent/CN1022035C/zh not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| IL89302A (en) | 1993-02-21 |
| DK74889D0 (da) | 1989-02-17 |
| HU206880B (en) | 1993-01-28 |
| CN1036761A (zh) | 1989-11-01 |
| DE68911944T2 (de) | 1994-05-19 |
| PH26260A (en) | 1992-04-01 |
| NZ227977A (en) | 1990-10-26 |
| CN1022035C (zh) | 1993-09-08 |
| US4866182A (en) | 1989-09-12 |
| KR890012983A (ko) | 1989-09-20 |
| CA1334201C (en) | 1995-01-31 |
| JP2811577B2 (ja) | 1998-10-15 |
| HUT54148A (en) | 1991-01-28 |
| KR960014794B1 (en) | 1996-10-19 |
| AU2990689A (en) | 1989-08-24 |
| ATE99681T1 (de) | 1994-01-15 |
| JPH02149571A (ja) | 1990-06-08 |
| DE68911944D1 (de) | 1994-02-17 |
| NO890681D0 (no) | 1989-02-17 |
| PT89749A (pt) | 1989-10-04 |
| FI890694A0 (fi) | 1989-02-14 |
| EP0329070A1 (en) | 1989-08-23 |
| PT89749B (pt) | 1994-03-31 |
| FI890694A (fi) | 1989-08-19 |
| EP0329070B1 (en) | 1994-01-05 |
| ES2061748T3 (es) | 1994-12-16 |
| ZA891111B (en) | 1989-10-25 |
| IL89302A0 (en) | 1989-09-10 |
| DK74889A (da) | 1989-08-19 |
| AU614029B2 (en) | 1991-08-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2058342T3 (es) | Pirroles, pirazoles y triazoles sustituidos antagonistas de la angiotensina ii. | |
| ES2062403T3 (es) | 5-((tetrazolil)-alquenil)-imidazoles sustituidos. | |
| NO895086L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske forbindelser. | |
| AU1611192A (en) | Fibrinogen receptor antagonists | |
| ES2115163T3 (es) | Procedimiento para inhibir la proliferacion de celulas de musculos lisos y la restinosis. | |
| NO872863L (no) | Analogifremgangsmte for fremstilling av terapeutiske imidazoler som blokkerer angiotensin-ii-reseptorer. | |
| NO895170D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive 7-oksabicykloheptyl-substituerte heterocyklisk amid-prostaglandinanaloger. | |
| NO890681L (no) | Fremgangsmaate for fremstilling av alkanoyl- og aroyloxazoloner. | |
| NO161564C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive beta-carbolin-3-oxadiazolylderivater. | |
| GR860707B (en) | Herbicide and insecticide means based on pyrazol derivatives | |
| NO872382L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske forbindelser. | |
| EP0357201A3 (en) | Pyridyl pyrimidinone derivatives with an insecticidal activity | |
| SG48250A1 (en) | 4-substituted dihydropyrido (4,3-d) pyrimidines as analgesics and topical antiinflammatory agents forthe treatment of skin disorders | |
| AU2346488A (en) | Ortho-substituted benzyl carboxylates and fungicides which contain these compounds | |
| NZ216334A (en) | Spiro imidazolone derivatives and pharmaceutical composition | |
| NO883776L (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater. | |
| AU1282788A (en) | 3-(2-haloethyl)-1,4-oxathiins and 2-(2-haloethyl)-1,4-dithiins and treatment of leukemia and tumors therewith | |
| AU8114387A (en) | Use of 5-(substituted phenyl)-oxazolidinone derivatives for treatment of depression | |
| AU555244B2 (en) | Substituted alkanoylimidazol-2-one derivatives | |
| TR199701604T2 (xx) | Pirol t�revleri i�in yeni ba�vuru | |
| NO171639C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive imidazolpyrazolderivater | |
| EP0337350A3 (en) | Use of dimethylheptylphenyl butanoyl ethanolamine in treatment of hyperuricemia | |
| JO1599B1 (en) | Therapeutic agents | |
| NO870499D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske forbindelser. | |
| NO882636D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive oksygenholdige heterocykliske forbindelser. |